Victoria Forster, PhD

In the last few years, cancer research has been hindered by the COVID-19 pandemic, Brexit, the war in Ukraine, and tensions between world superpowers.

Cancer patients have voiced concerns about a lack of masking at cancer centers and have reported being harassed for wearing masks in public.

Women in academic medicine typically have lower starting salaries than men, and this disparity remains after 10 years on the job.

Patients with certain cancers have an increased risk of cancer-specific mortality that persists for 30 to 35 years after diagnosis.

The efficacy of many combination therapies may be due to independent drug action, not synergistic or additive effects.

Researchers have summarized what is known about COVID-19 in the context of lung cancer and highlighted areas where more research is needed.

There have been some concerns that the immunomodulatory effect of PD-1 blockade may influence the response of patients with cancer to COVID-19.